Pendley, Baudin & Coffin, L.L.P. is proud to announce Chris Coffin's appointment to a top leadership position on the Plaintiffs' Steering Committee in the Taxotere multi-district litigation. As Co-Lead Counsel in the national litigation, Chris will be responsible for managing the Plaintiffs' Steering Committee which has been tasked with coordinating the efforts of all Taxotere permanent hair loss cases for plaintiffs across the U.S.
Pendley, Baudin & Coffin, L.L.P. takes pleasure in announcing that Courtney L. Stidham has recently joined the firm as an associate in its New Orleans office.
Courtney practices in multiple areas of civil litigation, including class actions, mass torts, products liability, and personal injury. Before joining PBC, Courtney represented clients in the areas of consumer fraud, toxic torts, environmental issues, contract disputes, and class action litigation.
The attorneys at Pendley, Baudin & Coffin, L.L.P. are currently investigating potential legal action on behalf of patients who have been implanted with the Attune© Knee System made by DePuy Synthes, and are now having DePuy knee replacement implant problems.
While modern medicine increasingly uses automated machines and devices to treat a wide variety of illnesses, the equipment itself can sometimes be linked to dangerous or even fatal issues. The public relies on federal regulators to adequately monitor these types of issues and ultimately ensure patient safety, but when that oversight fails, the consequences can be deadly.
PBC is pleased to announce that its own Chris Coffin has been appointed to the Plaintiffs' Steering Committee that will take the lead on all federal Taxotere litigation for plaintiffs throughout the U.S.
Taxotere, a chemotherapy drug manufactured by Sanofi-Aventis and primarily used to treat breast cancer, is linked to permanent hair loss or "alopecia" in women who were undergoing treatment for breast cancer.
We are currently investigating and accepting claims and filing cases for anyone that has been exposed to the commercial herbicide and weed killer, Roundup, on their farm, home or on the job and who were diagnosed with certain cancers. Roundup, or glyphosate, has been recently scientifically linked to Non-Hodgkin's Lymphoma and other cancers.
Class members who submitted timely and valid claims for the pediatric Celexa, Lexapro settlement began receiving checks on June 27, 2016. The class action accused Celexa and Lexapro manufacturer, Forest Laboratories, of improperly marketing the medications to minors under the age of 18. The plaintiffs are represented by Baum, Hedlund, Aristei & Goldman, PC and Pendley, Baudin & Coffin, L.L.P. Click here to read more.
Patrick Pendley of Pendley, Baudin & Coffin, L.L.P. presented a $290,000 check to ARC-Iberville after winning a class action settlement filed against British Petroleum after the spill in the Gulf of Mexico.
Law360, New York (May 9, 2016, 4:05 PM ET) -- Health care fund providers seeking to recover money lost because of Forest Laboratories' allegedly fraudulent promotion of its drugs in treating pediatric depression pressed a Massachusetts federal judge to certify their portion of the multidistrict litigation as a class, saying previous court rulings and
The lawyers at Pendley, Baudin and Coffin LLP are representing women across the country who have suffered severe permanent hair loss (alopecia) as a result of taking Taxotere, a chemotherapy drug used to treat multiple forms of cancer. Each Taxotere hair loss case will be given the individual care and attention that it deserves and will not be pursued as part of a class action lawsuit.